3 Exciting Cannabis Stocks to Buy Right Now

The cannabis industry is booming with opportunistic stocks that can bring in higher returns with a little bit of patience. The U.S. cannabis space in particular is sizzling with excellent pot companies that are growing revenues drastically; some of them are even profitable. As state legalization continues to ramp up…

with the prospect of federal legalization rising, the future looks bright for cannabis players. But in an evolving industry, smaller companies with tremendous growth potential often get sidelined by bigger companies.

While all eyes are on established names like Trulieve CannabisCuraleaf Holdings, and Green Thumb Industries, the following three small-cap companies often get ignored. But these multistate operators (MSOs) are rising stars that can make investors rich over the long term — their recent quarterly results are proof of that. Let’s take a look at each.

1. Jushi Holdings

This small-cap pure-play cannabis company with a market cap of just $785 million has tremendous potential to shine as the cannabis industry expands. Even with just 26 retail stores nationwide, Florida-based Jushi Holdings (OTC:JUSHF) has been growing revenue drastically. In its third quarter of 2021, revenue jumped 117% year over year to $54 million. Its wise strategy of targeting limited license markets has worked in its favor.

Jushi has come a long way from just $110,000 in revenue in Q2 2018 to $54 million now. Since cannabis is illegal at the federal level, many states are restrictive of the number of licenses they issue. Having a market presence in limited license states (like Pennsylvania, Illinois, California, and Virginia) has led the company to a net profit of $38.2 million, compared to a net loss of $29.4 million in the year-ago period. Sequentially, net income also jumped from $4.8 million in Q2 2021. 

Recently, Jushi opened its second store in Virginia and can take advantage of the new recreational market in the state once sales begin. Jushi has managed to keep its balance sheet stable while continuing with its expansion plans. At the end of Q3, it had $94 million in cash and short-term investments and $142 million in principal amount of total debt (excluding current leases and financing obligations related to plants and equipment).

2. Columbia Care

With a market cap of just $1.1 billion, the New York-based MSO Columbia Care (OTC:CCHWF) is working wonders. It follows the same strategy as Jushi of targeting limited license markets, which helps it garner a loyal customer base. This strategy brought in a whopping 144% year-over-year increase in total revenue to $132 million in the third quarter of 2021. The company also saw an outstanding jump of 634% in adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) to $31 million from Q3 2020. Columbia Care gives credit to the key cannabis markets of California, Colorado, Massachusetts, Ohio, Pennsylvania, Illinois, Maryland, and Virginia for this performance.

Due to regulatory challenges with opening dispensaries in a few states and the delayed implementation of recreational markets in some states, management revised the company’s 2021 guidance. It now expects revenue to be in the range of $470 million to $485 million, adjusted EBITDA to be in the range of $85 million to $95 million, and adjusted gross profit margin to be around 46% for the year. 

Despite all the external headwinds…

 

Continue reading at THE MOTLEY FOOL

 

Leave a Reply

Your email address will not be published. Required fields are marked *